Oncotarget; the Start of the Beginning of an Affliction-Free World

Oncotarget is a weekly medical journal peer-reviewed and later published by Impact Journals. The journal was founded at the start of 2010. There has been a couple of editors-in-chief since her genesis, but she is currently under the stewardship of Mikhail Blagosklonny and Andrei V Gudkov. Bibliographic databanks like the Scopus, PubMed, Index Medicus, Bioisis Preview, and Medline are some of the platforms you can visit to have access to this weekly publications. Download output styles at Endnote.com.

Oncotarget was formed with the objective of spreading across all scientific works and research. Her founders also wanted to bridge a gap between specialties. Oncotarget publishes studies that highlight issues such as Microbiology, Cancers, Aging, Cardiology, Pharmacology, Cell Biology and Neuroscience. It is cancer research. However, that takes the day. The magazine also focuses on the development and management of various tumors.

The journal is, in recent years, showing a lot of development and progress. Publishing twice a week is one such progress.

The magazine is also set to make permanent her appearance on PubMed, this will, however, only be done after page and issue numbers have been assigned. It is also important to know that Oncotarget will be the first of her kind to submit an entire issue to PubMed with only a few days after being published online. Read more about Oncotarget at Business Insider.

With 7 of her issues already on paper, the well-established journal is now working on her eighth, this tied with the fact that she already has 324 volumes to her name, is also significant progress. Content published in the journal is of high quality and standards. Researchers’ essays have to go through the Direct Object Identifier, DOI, and later the Committee on Publication Ethics.

‘Fight and eliminate disease’ is the vision that guides Oncotarget. The platform invites all researchers and scientists to help in the realization of this concept. It encourages them to focus on clinical and basic science to combat the disease. Cancer is one disease the journal delves deep into in an attempt to find closure. The journal has shed light on the best therapy treatments for cancer patients. It has gone a step ahead to publish on how best to care for this patients; palliative care is of vital importance. Palliative care focuses more on making minimal the effects of the disease rather than finding a cure for the sickness.

Visit: https://www.facebook.com/Oncotarget/